BARCLAYS PLC - TITAN PHARMACEUTICALS INC DE ownership

TITAN PHARMACEUTICALS INC DE's ticker is TTNP and the CUSIP is 888314309. A total of 1 filers reported holding TITAN PHARMACEUTICALS INC DE in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of TITAN PHARMACEUTICALS INC DE
ValueSharesWeighting
Q4 2018$0150
+200.0%
0.00%
Q3 2018$0500.0%0.00%
Q2 2018$0500.0%0.00%
Q1 2018$050
-66.7%
0.00%
Q4 2017$0
-100.0%
150
-99.4%
0.00%
Q2 2017$47,000
+161.1%
24,676
+341.7%
0.00%
Q1 2017$18,000
+1700.0%
5,587
+1478.2%
0.00%
Q4 2016$1,0000.0%354
+200.0%
0.00%
Q3 2016$1,0001180.00%
Other shareholders
TITAN PHARMACEUTICALS INC DE shareholders Q1 2019
NameSharesValueWeighting ↓
THOMPSON DAVIS & CO., INC. 16,184$95,0000.17%
Acrospire Investment Management LLC 30,847$181,0000.12%
Spark Investment Management LLC 24,000$141,0000.01%
ACCURATE INVESTMENT SOLUTIONS, INC. 2,000$12,0000.01%
Blume Capital Management, Inc. 2,546$15,0000.01%
BLUESTEIN R H & CO LLC 20,000$118,0000.01%
Virtu KCG Holdings LLC 42,562$250,0000.01%
ARCADIA INVESTMENT MANAGEMENT CORP/MI 1,819$11,0000.00%
Integrated Wealth Management 910$5,0000.00%
Krilogy Financial LLC 800$5,0000.00%
View complete list of TITAN PHARMACEUTICALS INC DE shareholders